UVA School of Medicine emeritus professor Dr. Frederick G. Hayden helped design the trial and presented the results Wednesday ...
BullFrog AI plans to introduce what it considers a game-changing approach that could shorten timelines, reduce costs, and ...
New SEC filings from pharmaceutical companies reveal Donald Trump and Elon Musk’s cost-cutting measures could slow drug ...
Scientists have developed a coffee machine-sized 3D bioprinter that produces human-like tissue in a move they hope could potentially speed up the development of new treatments for the likes of heart ...
Pharmaceutical Executive: Can you describe South Rampart’s work in pain medication? Dr. Hernan Bazan: For several years now, we've been working on the development of a novel manipulated small molecule ...
The American public lacks transparency regarding the origin of their medications, and the assumption that their drugs come ...
It usually takes more than a decade for a drug company to recoup the amount of money they put into the development of new ...
2d
News-Medical.Net on MSNNew automated system revolutionizes drug evaluation in zebrafishPreclinical drug evaluation, especially for cardiotoxicity, is a critical stage in the drug development process.
The investment of over $6 million will expand LGM Pharma’s Rosenberg, Texas manufacturing facility as part of its Phase I ...
8d
News Medical on MSNNew insights into drug addiction: The role of astrocytic G protein-coupled receptorsA new study in Engineering explores the role of astrocytic G protein-coupled receptors in drug addiction. It shows that these ...
Optum Rx, the pharmacy benefit manager owned by UnitedHealth Group, placed Journavx on some of its commercial formularies in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results